Two functional epitopes of pigment epithelial–derived factor block angiogenesis and induce differentiation in prostate cancer S Filleur, K Volz, T Nelius, Y Mirochnik, H Huang, TA Zaichuk, ... Cancer research 65 (12), 5144-5152, 2005 | 218 | 2005 |
Binding of pigment epithelium-derived factor (PEDF) to retinoblastoma cells and cerebellar granule neurons: evidence for a PEDF receptor E Alberdi, MS Aymerich, SP Becerra Journal of Biological Chemistry 274 (44), 31605-31612, 1999 | 204 | 1999 |
Direct involvement of σ-1 receptors in the dopamine D1 receptor-mediated effects of cocaine G Navarro, E Moreno, M Aymerich, D Marcellino, PJ McCormick, J Mallol, ... Proceedings of the National Academy of Sciences 107 (43), 18676-18681, 2010 | 190 | 2010 |
Effective GDNF brain delivery using microspheres—a promising strategy for Parkinson's disease E Garbayo, CN Montero-Menei, E Ansorena, JL Lanciego, MS Aymerich, ... Journal of Controlled Release 135 (2), 119-126, 2009 | 180 | 2009 |
Identification of the neuroprotective molecular region of pigment epithelium-derived factor and its binding sites on motor neurons MM Bilak, SP Becerra, AM Vincent, BH Moss, MS Aymerich, RW Kuncl Journal of Neuroscience 22 (21), 9378-9386, 2002 | 145 | 2002 |
Expression of the mRNAs encoding for the vesicular glutamate transporters 1 and 2 in the rat thalamus P Barroso‐Chinea, M Castle, MS Aymerich, M Pérez‐Manso, E Erro, ... Journal of Comparative Neurology 501 (5), 703-715, 2007 | 117 | 2007 |
Cannabinoid pharmacology/therapeutics in chronic degenerative disorders affecting the central nervous system MS Aymerich, E Aso, MA Abellanas, RM Tolon, JA Ramos, I Ferrer, ... Biochemical pharmacology 157, 67-84, 2018 | 115 | 2018 |
GPR55: A therapeutic target for Parkinson's disease? M Celorrio, E Rojo-Bustamante, D Fernández-Suárez, E Sáez, ... Neuropharmacology 125, 319-332, 2017 | 110 | 2017 |
Thalamic innervation of the direct and indirect basal ganglia pathways in the rat: Ipsi‐and contralateral projections M Castle, MS Aymerich, C Sanchez‐Escobar, N Gonzalo, JA Obeso, ... Journal of Comparative Neurology 483 (2), 143-153, 2005 | 110 | 2005 |
Striatal expression of GDNF and differential vulnerability of midbrain dopaminergic cells P Barroso‐Chinea, I Cruz‐Muros, MS Aymerich, M Rodríguez‐Díaz, ... European Journal of Neuroscience 21 (7), 1815-1827, 2005 | 103 | 2005 |
The monoacylglycerol lipase inhibitor JZL184 is neuroprotective and alters glial cell phenotype in the chronic MPTP mouse model D Fernández-Suárez, M Celorrio, JI Riezu-Boj, A Ugarte, R Pacheco, ... Neurobiology of Aging 35 (11), 2603-2616, 2014 | 97 | 2014 |
Thalamic innervation of striatal and subthalamic neurons projecting to the rat entopeduncular nucleus JL Lanciego, N Gonzalo, M Castle, C Sanchez‐Escobar, MS Aymerich, ... European Journal of Neuroscience 19 (5), 1267-1277, 2004 | 94 | 2004 |
Consequences of unilateral nigrostriatal denervation on the thalamostriatal pathway in rats MS Aymerich, P Barroso‐Chinea, M Pérez‐Manso, AM Munoz‐Patino, ... European Journal of Neuroscience 23 (8), 2099-2108, 2006 | 89 | 2006 |
Interactions between calmodulin, adenosine A2A, and dopamine D2 receptors G Navarro, MS Aymerich, D Marcellino, A Cortés, V Casadó, J Mallol, ... Journal of Biological Chemistry 284 (41), 28058-28068, 2009 | 84 | 2009 |
Gut microbial dysbiosis after traumatic brain injury modulates the immune response and impairs neurogenesis M Celorrio, MA Abellanas, J Rhodes, V Goodwin, J Moritz, S Vadivelu, ... Acta Neuropathologica Communications 9 (1), 1-22, 2021 | 83 | 2021 |
Fatty acid amide hydrolase inhibition for the symptomatic relief of Parkinson’s disease M Celorrio, D Fernández-Suárez, E Rojo-Bustamante, V Echeverry-Alzate, ... Brain, Behavior, and Immunity 57, 94-105, 2016 | 74 | 2016 |
Structures for G-protein-coupled receptor tetramers in complex with G proteins A Cordomí, G Navarro, MS Aymerich, R Franco Trends in biochemical sciences 40 (10), 548-551, 2015 | 73 | 2015 |
Pharmacologic antagonism of dopamine receptor D3 attenuates neurodegeneration and motor impairment in a mouse model of Parkinson's disease D Elgueta, MS Aymerich, F Contreras, A Montoya, M Celorrio, ... Neuropharmacology 113, 110-123, 2017 | 70 | 2017 |
Sustained release of bioactive glycosylated glial cell-line derived neurotrophic factor from biodegradable polymeric microspheres E Garbayo, E Ansorena, JL Lanciego, MS Aymerich, MJ Blanco-Prieto European journal of pharmaceutics and biopharmaceutics 69 (3), 844-851, 2008 | 66 | 2008 |
GPR40 activation leads to CREB and ERK phosphorylation in primary cultures of neurons from the mouse CNS and in human neuroblastoma cells M Zamarbide, I Etayo‐Labiano, A Ricobaraza, E Martínez‐Pinilla, ... Hippocampus 24 (7), 733-739, 2014 | 63 | 2014 |